CTI BioPharma Corp. (NASDAQ and MTA: CTIC) announced today that pacritinib has been granted Fast Track designation by the FDA ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE